Publications by authors named "Lina Marie"

Claim this Profile
T
Therapy-related Myeloid Neoplasms After Autologous Stem Cell Transplantation for Lymphoma: A Single-Center Experience.
Abeer Yaseen, Anas Zayed, Mona Ribie, Albatol Alamoush, Yazan Talab, Lina Marie

Blood Cell Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Characteristics and Outcomes of CML in Adolescents and Young Adults.
Kamal Al-Rabi, Mohammad Ma'koseh, Fadwa Al-Qadi, Ali A Hanoon, Waleed Da'na, Lina Marie

Clin Lymphoma Myeloma Leuk· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Characteristics, Prognostic Factors and Treatment Outcomes of Patients with Bone-Only Metastatic Breast Cancer.
Lina Marie, Dina Braik, Nayef Abdel-Razeq, Hala Abu-Fares, Ahmad Al-Thunaibat

Cancer Manag Res· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic Epidemiology of SARS-CoV-2 in Seychelles, 2020-2021.
John Mwita Morobe, Brigitte Pool, Lina Marie, Dwayne Didon, Arnold W Lambisia

Viruses· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dietary inflammatory index and odds of breast cancer: A case-control study.
Shatha S Hammad, Reema Mahmoud, Nitin Shivappa, James R Hebert, Lina Marie

Food Sci Nutr· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of FLT3-Activating Mutations in Patients With Acute Myelogenous Leukemia in Jordan: Association With FAB Subtypes and Identification of Subgroups With Poor Prognosis.
Khalid Halahleh, Ayat Taqash, Hadeel Abdelkhaleq, Mohamad Manasrah, Lina Marie

Clin Lymphoma Myeloma Leuk· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Four cycles of adriamycin and cyclophosphamide followed by four cycles of docetaxel (NSABP-B27) with concomitant trastuzumab as neoadjuvant therapy for high-risk, early-stage, HER2-positive breast cancer patients.
Hikmat Abdel-Razeq, Salwa S Saadeh, Mahmoud Abu-Nasser, Hazem Abdulelah, Lina Marie

Onco Targets Ther· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis